INSIGHTS ON DRUG DEVELOPMENT
-
Optimize Your mAb Capture And Polishing With The Latest Resins And Tips
Discover the latest innovations in monoclonal antibody purification and explore resin selection strategies to optimize product quality and improve process efficiency.
-
Selecting A CDMO For Custom Activated PEGs
Custom-activated PEGs require thoughtful planning and precise analytical control. Discover key considerations for selecting a partner capable of supporting scalable, compliant PEGylation.
-
EMA Support For SMEs Through Scientific Advice And Early Dialogue
Discover how early engagement with European regulators helps smaller drug developers reduce uncertainty, clarify requirements, and de‑risk innovative programs through early dialogue.
-
Patented Process For Intermediates Useful For Etrasimod Arginine
Explore how rethinking the synthetic strategy for Etrasimod can overcome the limitations of legacy routes, enabling more efficient chirality control, improved scalability, and more practical industrial API production.
-
Automated Bioburden Testing Solution11/7/2025
Automation is transforming microbial quality control labs, boosting productivity, minimizing errors, and ensuring data integrity. Discover how digitalization is driving Pharma 4.0 and reshaping lab workflows.
-
Polymorphism 101: What Early-Stage Drug Developers Need To Know To Reduce Risk5/18/2026
Polymorphism impacts solubility, stability, and manufacturability, making early solid‑form screening critical to reduce risk, guide development decisions, and ensure consistent performance.
-
Right From The Start: Smarter Developability For Stronger Formulations2/4/2026
Early developability assessment integrates manufacturability, QbD, flexible formulations, and CDMO support to cut risk, speed development, and enable scalable, robust drugs.
-
Safety First: Considerations When Formulating High Potency Compounds9/23/2026
Developing highly potent APIs comes with unique challenges. Explore strategies for managing risk, protecting personnel, and advancing programs with confidence.
-
Aggregate Analysis Of Semaglutide12/11/2025
Effective size exclusion chromatography (SEC) for Semaglutide aggregate analysis is possible without high organic solvents or acidic modifiers. Learn about this robust method for improved efficacy.
DRUG DEVELOPMENT SOLUTIONS
-
Enhance your workflow with the Avanti JXN-26 high-speed Centrifuge System
- 6.0 L Max Capacity
- 26,000 RPM
- 81,770 x g
-
Curia’s discovery biology team accelerates your program toward the clinic and commercialization with our best-in-class, customizable solutions.
-
Our expertise and capabilities enable us to meet the complex technical challenges of pediatric products and provide you with a unique integrated development solution.
-
Flexible, reliable control and bioreactor systems for laboratory applications
Thermo Scientific™ HyPerforma™ bioprocess control systems are designed to optimize your process from the laboratory bench to full cGMP manufacturing. Our innovative control platform combines a flexible operating system with scalable, modular hardware, novel single-use sensors, and state-of-the-art bioreactors for strategic and streamlined bioprocess control.
HyPerforma benchtop solutions offer robust management of both cell culture and fermentation processes. The open architecture provides process flexibility, and dedicated hardware control allows for expansion. Thermo Scientific™ TruBio™ software is designed to support easy process control and scaling.
-
Cambrex’s understanding of crystal formation and thermodynamics allows us to develop custom, scalable crystallization processes for peptides. We leverage the right tools with the best experts to bridge success from the bench to the plant.